Pfizer CEO Albert Bourla calls Israel ‘laboratory of the world’ in NBC interview

“I believe Israel has become the laboratory of the world right now because they only use our vaccine in this state and they have vaccinated a very large part of their population, so we can study both the economic and health indices, “Pfizer CEO Albert Bourla said in an interview with NBC News on Friday.

“What we have seen is that the efficacy of the vaccine in real world data is increasing as we speak, after the second vaccination, so seven days compared to 14 days after the second vaccination, there is a difference in efficiency, ”Bourla said. .

When asked if we could infect other people after receiving two doses of the vaccine, he said, “This is something that needs to be confirmed, and the actual data that we are getting from Israel and further studies will help us better understand this.

Bourla further noted that studies on the risk of the vaccine are also underway in pregnant women and young children.

“We already have licenses for kids 16 and over … we’re already testing kids 11-16, and hopefully we can have some data in a few months. We are also planning to start pediatric studies at a younger age, 5 to 11 years old. And I think we should have data on that population by the end of the year, ”Bourla said, according to NBC.

Regarding the duration of protection after receiving the two doses of the vaccine, Bourla said current data shows that after six months the protection is robust, but we have to wait up to a year to determine if it is. lasts all year round.